Management of Chronic Insomnia in the Elderly
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for chronic insomnia in elderly patients due to its proven efficacy, sustained long-term benefits, and minimal side effects. 1, 2
Assessment Approach
When evaluating an elderly patient with chronic insomnia, focus on:
- Duration of symptoms (at least 1 month with daytime impairment)
- Medication review (β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, SNRIs)
- Over-the-counter preparations (pseudoephedrine, caffeine-containing drugs)
- Comorbid medical and psychiatric conditions
- Current sleep habits and behaviors
Treatment Algorithm
Step 1: Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I has demonstrated superior efficacy compared to medications, with benefits lasting up to 2 years after treatment 1. It includes:
- Sleep restriction therapy: Limiting time in bed to match actual sleep time
- Stimulus control: Strengthening association between bed and sleep
- Cognitive restructuring: Addressing maladaptive thoughts about sleep
- Sleep hygiene education: Modifying behaviors that interfere with sleep
A randomized controlled trial comparing CBT to zopiclone in older adults found that CBT resulted in improved sleep efficiency from 81.4% at pretreatment to 90.1% at 6-month follow-up, while the zopiclone group showed a decrease from 82.3% to 81.9% 3.
Step 2: Address Sleep Hygiene Issues
While sleep hygiene alone is insufficient for treating chronic insomnia 1, addressing these factors is important:
- Eliminate daytime napping
- Avoid spending excessive time in bed
- Increase daytime activities
- Avoid late evening exercise
- Increase bright light exposure during the day
- Eliminate caffeine, alcohol, and nicotine
- Create optimal sleep environment (temperature, noise, light)
Step 3: Consider Pharmacotherapy (Only if CBT-I is Unsuccessful)
If CBT-I alone is unsuccessful, consider short-term medication use through shared decision-making 1:
For sleep onset insomnia:
- Ramelteon 8mg (fewer side effects in elderly)
- Low-dose zolpidem 5mg (elderly)
For sleep maintenance insomnia:
- Low-dose doxepin 3-6mg
- Eszopiclone 1-2mg (lower dose for elderly)
- Suvorexant 10mg (elderly)
Important Considerations and Cautions
Avoid benzodiazepines in elderly patients due to increased risk of falls, cognitive impairment, and dependency 2, 4.
Limit medication duration to the shortest effective period to minimize risks 2.
Monitor for adverse effects of medications, particularly in the elderly:
- Daytime sedation
- Falls
- Cognitive impairment
- Complex sleep behaviors (sleep-driving, sleep-eating)
Melatonin has limited evidence for efficacy in the elderly, with only slight improvements in sleep onset and duration 4.
Combination therapy (CBT-I plus medication) may provide better short-term outcomes than either approach alone, but behavioral interventions produce more sustained benefits 5.
Follow-up and Monitoring
- Use standardized measures like the Insomnia Severity Index (ISI) to track progress
- Schedule follow-up within 7-10 days of initiating treatment
- If using medications, implement gradual tapering when discontinuing to prevent withdrawal symptoms
Pitfalls to Avoid
- Relying solely on medications for long-term management
- Overlooking medical causes of insomnia (pain, sleep apnea, depression)
- Using sleep hygiene education alone without comprehensive CBT-I
- Prescribing inappropriate doses of hypnotics for elderly patients
- Continuing ineffective treatments without reassessment
The evidence clearly demonstrates that CBT-I provides the best balance of efficacy and safety for elderly patients with chronic insomnia, with more sustainable benefits than pharmacotherapy 1, 3.